Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jenkins

Showing results (431-440 of 799) with videos related to

Pageof 80
Sort By:
Journal of Neuropathology and Experimental Neurology|August 3, 2019
Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical BehaviorAmy A Swanson, Aditya Raghunathan, Robert B Jenkins, et al.
American Journal of Clinical Pathology|August 1, 1991
Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disordersC R Schad, W J Kraker, S M Jalal, et al.
Cancer Genetics and Cytogenetics|October 25, 1991
Cytogenetics of six follicular thyroid adenomas including a case report of an oxyphil variant with t(8;14)(q13;q24.1)M A Herrmann, I D Hay, D H Bartelt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinomaS Takahashi, A Alcaraz, J A Brown, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Council Lung Cancer Working PartyN Thatcher, P I Clark, D B Smith, et al.
Cancer Research|September 17, 2008
P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock responseAndrea K McCollum, Cynthia J TenEyck, Bridget Stensgard, et al.
Journal of Neuropathology and Experimental Neurology|October 25, 2023
Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutantAmir Nazem, Jonathan Lavezo, Zied Abdullaev, et al.
International Journal of Cancer|October 2, 2003
Microsatellite instability in hereditary and sporadic breast cancersCamilo Adem, Cheryl L Soderberg, Julie M Cunningham, et al.
Genes, Chromosomes & Cancer|April 30, 1999
Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancerJ B Villeneuve, M B Silverman, B Alderete, et al.
The Prostate|April 30, 1999
Mutation and expression analysis of the p73 gene in prostate cancerA Yokomizo, M Mai, D G Bostwick, et al.
Pageof 80

Showing results (431-440 of 799) with videos related to

Sort By:
Pageof 80
Journal of Neuropathology and Experimental Neurology|August 3, 2019
Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical BehaviorAmy A Swanson, Aditya Raghunathan, Robert B Jenkins, et al.
American Journal of Clinical Pathology|August 1, 1991
Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disordersC R Schad, W J Kraker, S M Jalal, et al.
Cancer Genetics and Cytogenetics|October 25, 1991
Cytogenetics of six follicular thyroid adenomas including a case report of an oxyphil variant with t(8;14)(q13;q24.1)M A Herrmann, I D Hay, D H Bartelt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinomaS Takahashi, A Alcaraz, J A Brown, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Council Lung Cancer Working PartyN Thatcher, P I Clark, D B Smith, et al.
Cancer Research|September 17, 2008
P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock responseAndrea K McCollum, Cynthia J TenEyck, Bridget Stensgard, et al.
Journal of Neuropathology and Experimental Neurology|October 25, 2023
Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutantAmir Nazem, Jonathan Lavezo, Zied Abdullaev, et al.
International Journal of Cancer|October 2, 2003
Microsatellite instability in hereditary and sporadic breast cancersCamilo Adem, Cheryl L Soderberg, Julie M Cunningham, et al.
Genes, Chromosomes & Cancer|April 30, 1999
Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancerJ B Villeneuve, M B Silverman, B Alderete, et al.
The Prostate|April 30, 1999
Mutation and expression analysis of the p73 gene in prostate cancerA Yokomizo, M Mai, D G Bostwick, et al.
Pageof 80